SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

The Fundrise Innovation Fund ($VCX) is seeing intense volatility and speculative interest following its recent market debut, with the community actively debating whether it is a legitimate vehicle for private equity exposure or a highly overvalued pump-and-dump scheme. Investors are fixated on the fund's heavy concentration in high-profile pre-IPO tech firms like Anthropic and SpaceX, while many remain frustrated by a six-month lock-up period that limits liquidity for early participants.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is facing significant downward pressure and intense community debate surrounding regulatory risks, Medicare reimbursement uncertainty, and potential balance sheet strain. While some investors see a long-term value opportunity at current levels, others are expressing concern over the company's technical weakness and its ability to navigate a challenging macroeconomic and political landscape.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the following segments: B&W Renewable, B&W Environmental, and B&W Thermal. The B&W Renewable segment supports a circular economy, diverting waste from landfills to use for power generation and replacing fossil fuels, while recovering metals and reducing emissions. The B&W Environmental segment focuses on systems for cooling, ash handling, particulate control, nitrogen oxides and sulfur dioxides removal, chemical looping for carbon control, and mercury control. The B&W Thermal segment offers steam generation equipment, aftermarket parts, construction, maintenance, and field services for plants in the power generation, oil and gas, and industrial sectors. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox shares are experiencing significant volatility driven by the full notice to proceed on a massive $2.4 billion contract to build natural gas-fired power generation for AI data centers. Investors are actively debating the company's valuation, institutional backing, and the long-term impact of this infrastructure expansion as the market monitors the firm's transition into a key player for AI energy requirements.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is facing significant downward pressure and intense community debate as investors grapple with a sharp post-earnings sell-off that has defied positive analyst sentiment. Shareholders are actively questioning whether the volatility is driven by broader market instability and geopolitical tensions, or if it reflects deeper concerns over potential management alignment with a low-cost acquisition strategy.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

The SPERMWHALE meme coin is generating significant buzz as traders debate whether it could replicate the explosive momentum seen in similar speculative crypto assets. While some investors focus on signs of accumulation and relative price stability, others remain skeptical, warning of the risks inherent in such volatile market activity.

The Estée Lauder Companies, Inc. engages in the manufacture of skin care, makeup, fragrance and hair care products. It sells products under Estée Lauder, Clinique, Origins, MAC, Bobbi Brown, La Mer, Jo Malone London, Aveda and Too Faced. The company was founded by Estee Lauder and Joseph Lauder in 1946 and is headquartered in New York, NY.

Estee Lauder Cos., Inc. - Ordinary Shares - Class A

Estee Lauder Cos. Inc

Estee Lauder is at the center of investor focus following reports that it is in merger discussions with Spanish beauty group Puig. While the market is reacting to potential dilution risks and broader concerns over debt, the community is actively debating the deal's strategic viability versus its potential downside, with some seeing a long-term turnaround opportunity.

The Graph is an indexing protocol and global API for organizing blockchain data and making it easily accessible with GraphQL. Developers can use Graph Explorer to search, find, and publish all the public data they need to build decentralized applications. The Graph Network makes it possible to build serverless dApps that run entirely on public infrastructure.  GRT is the native token of the network that’s used to coordinate work. GRT is an ERC20 token. Node operators, called Indexers, stake and earn GRT for processing queries. Anyone can delegate GRT to Indexers to secure the network and earn rewards. Curators organize data on The Graph by signaling GRT on useful APIs, called subgraphs. Indexers, Delegators, and Curators work together to organize the data for the crypto economy and maintain a useful global API for DeFi and Web3.

The Graph

The Graph is capturing significant community attention as investors debate its role as critical web3 infrastructure versus concerns over token supply dilution, while recent protocol upgrades like the integration of Anthropic's Model Context Protocol continue to drive technical interest. While some traders view the current price as an undervalued accumulation opportunity for the long term, others remain skeptical, focusing on historical price volatility and questioning whether the project can reclaim its prior highs.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is attracting investor interest following recent insider buying from CEO Seth Lederman and positive developments in the commercial launch of their fibromyalgia treatment, TONMYA. While shareholders remain focused on the potential for future institutional growth and strategic partnerships, community discussions are currently centered on navigating ongoing volatility, monitoring weekly prescription trends, and evaluating the company's long-term cash runway.

The Aircoin memecoin was born from a viral Twitter post from March, 2014 which proclaimed the following:   Evolution: 1. Aircoin 2. Fartcoin 3. Artcoin  Aircoin was launched in August, 2025 and CTO'd twice, with the second CTO team bringing vast experience and expertise to the project. The team includes industry veterans and visual arts professionals.  Aircoin is destined for greatness as a premier memecoin on the BONK.fun platform.

aircoin

Aircoin is gaining significant traction within the Solana ecosystem as the community rallies around its unique PvE-focused approach and significant supply-lock mechanics. Investors are actively highlighting the project's consistent growth, strong social engagement, and long-term hold philosophy as key drivers separating it from short-term speculative memecoins.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is seeing significant volatility as investors react to a major new volume order for 800G transceivers from a hyperscale customer, fueling excitement about the company's role in AI infrastructure. While the community is actively debating the stock's long-term growth potential and recent share offerings, momentum traders are focused on the intense volume and price swings following the news.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Eledon Pharmaceuticals (NASDAQ:ELDN) Announces Quarterly Earnings Results, Beats Expectations By $0.10 EPS

Eledon Pharmaceuticals (NASDAQ:ELDN - Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.10) EPS for the quarter, beating analysts' consensus estimates of ($0.20) by $0.10...

Eledon Pharmaceuticals Touts Tegoprubart Safety in BESTOW Kidney Transplant Data at Leerink Conference

Eledon Pharmaceuticals (NASDAQ:ELDN) used a presentation at the Leerink Partners Global Healthcare Conference to highlight what CEO David-Alexandre Gros described as a rapid expansion in clinical...

Eledon Pharmaceuticals (ELDN) to Release Quarterly Earnings on Thursday

Eledon Pharmaceuticals (NASDAQ:ELDN) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 19. (View Earnings Report at...

NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes

NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance...

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Given Average Recommendation of "Hold" by Brokerages

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN - Get Free Report) has been given an average rating of "Hold" by the five research firms that are currently covering the stock, MarketBeat Ratings reports...

Eledon Pharmaceuticals Highlights BESTOW Data, Phase III Plans and FDA Timeline for Tego at Conference

Eledon Pharmaceuticals (NASDAQ:ELDN) executives discussed recent clinical results and upcoming regulatory plans for its investigational immunosuppressive therapy, referred to in the discussion as...

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Given Consensus Rating of "Hold" by Brokerages

Shares of Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN - Get Free Report) have received an average rating of "Hold" from the five research firms that are covering the stock, MarketBeat reports. One...

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Given Consensus Recommendation of "Hold" by Analysts

Shares of Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN - Get Free Report) have been given an average recommendation of "Hold" by the five research firms that are covering the company, Marketbeat...

The End of Shots? 5 Biotech Stocks Rethinking Diabetes

The End of Shots? 5 Biotech Stocks Rethinking Diabetes The End of Shots? 5 Biotech Stocks Rethinking Diabetes PR Newswire VANCOUVER, BC, Dec. 31, 2025 Issued on behalf of Avant Technologies Inc...

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Receives Average Rating of "Hold" from Analysts

Shares of Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN - Get Free Report) have been given a consensus rating of "Hold" by the five brokerages that are covering the stock, MarketBeat Ratings reports. One...

Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company, which engages in development of therapies to protect transplanted organs and prevent rejection. The firm also focuses on development of therapy to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, a humanized IgG1 anti-CD40L antibody with high affinity for CD40 ligand (CD40L), a biological target with broad therapeutic potential. The company was founded on March 26, 2004 and is headquartered in Irvine, CA.

Current Price	$3.10
Prev Close	$2.88
Open	$2.98
Dividend Yield	0.00%
50-Day Moving Average	$2.33
Beta	0.87
Avg. Volume	707,226.31
PE Ratio	-4.85

52-Week High	$4.60
52-Week Low	$1.35
Market Capitalization	$216.24M
EPS (Annual)	-$0.5574
Price to Book	2.68
Revenue Per Employee	$0.00

ELDN
Eledon Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ELDN News

ELDNEledon Pharmaceuticals Inc